Toggle navigation
Home
Submit
Login
Toggle navigation
Recent submissions
edepositIreland
School of Pharmacy and Pharmaceutical Sciences
Pharmacy and Pharmaceutical Sciences
Recent submissions
edepositIreland
School of Pharmacy and Pharmaceutical Sciences
Pharmacy and Pharmaceutical Sciences
Recent submissions
JavaScript is disabled for your browser. Some features of this site may not work without it.
Search DSpace
This Community
Browse
All of TARA
edepositIreland Collections
Titles
Authors
Date of Publication
Subjects
Sponsor
This Community
Titles
Authors
Date of Publication
Subjects
Sponsor
My Account
Login
Pharmacy and Pharmaceutical Sciences: Recent submissions
Now showing items 301-320 of 622
Alterations in Apoptosis-related Genes in Cell Line Models of Acquired Lapatinib Resistance, Identifies Potential Therapeutic Targets for the Treatment of Lapatinib Resistant HER2-positive
O'Driscoll, Lorraine
(
2012
)
The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.
O'Driscoll, Lorraine
(
2012
)
EGFR and HER2 inhibition in pancreatic cancer.
O'Driscoll, Lorraine
(
2013
)
Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells.
O'DRISCOLL, LORRAINE
(
2013
)
Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum-free media for mammalian cell culture.
O'DRISCOLL, LORRAINE
(
2006
)
Challenges in molecular analysis for individualized cancer therapy.
O'DRISCOLL, LORRAINE
(
2003
)
Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.
O'DRISCOLL, LORRAINE
(
1997
)
Neuromedin U to increase IL-6 levels and to expand cancer stem cells in HER2-positive breast cancer cells.
O'Driscoll, Lorraine
(
2015
)
The relevance of exosomes in prostate cancer and their potential to confer docetaxel resistance to secondary cells.
O'Driscoll, Lorraine
(
2012
)
The potential of miR-630, an IGF1R regulator, as a predictive biomarker for HER2-targeted drugs.
O'Driscoll, Lorraine
(
2013
)
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.
O'DRISCOLL, LORRAINE
(
2008
)
Prevalence and prognostic and predictive relevance of PRAME in breast cancer
O'DRISCOLL, LORRAINE
(
2008
)
Identification of a novel, functional role for S100A13 in invasive lung cancer cell lines.
O'DRISCOLL, LORRAINE
(
2008
)
Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'DRISCOLL, LORRAINE
(
2007
)
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.
O'DRISCOLL, LORRAINE
(
2007
)
Detecting de novo insulin synthesis in embryonic stem cell-derived populations.
O'DRISCOLL, LORRAINE
(
2007
)
Setting up a Cell Culture Laboratory
O'Driscoll, Lorraine
(
Elsevier Academic Press
,
2006
)
Proteomic analysis of conditioned media from glucose responsive and glucose non-responsive phenotypes reveals a panel of secreted proteins associated with beta cell dysfunction.
O'DRISCOLL, LORRAINE
(
2008
)
Proteomic screening of glucose-responsive and glucose non-responsive MIN-6 beta cells reveals differential expression of proteins involved in protein folding, secretion and oxidative stress.
O'DRISCOLL, LORRAINE
(
2006
)
Multiple drug resistance in variants of a human lung cell line exposed to adriamycin and VP-16.
O'Driscoll, Lorraine
(
1995
)
